Litecoin is no longer limited to individual payments. It is being integrated into business strategies. It becomes a treasury tool. It becomes a trusted asset.
Why did MEI bet on Litecoin instead of Ethereum or Bitcoin? The answer is twofold: efficiency and discretion.
At the same time, Litecoin shows massive use in payments. In BitPay, it sometimes even surpasses bitcoin in transaction volume.
Beyond the technical narrative, the numbers speak:
◽12.5% increase in LTC in 24 hours after the announcement;
◽83% profit in pre-market for MEIP;
◽29.2 million shares sold at $3.42 to finance the operation;
◽151% increase in Litecoin treasury for Luxxfolio;
◽$100 million allocated exclusively to the purchase of LTC.
The message is clear: Litecoin is no longer a secondary currency. It is an investment tool, a response to volatility, a strategic alternative.
MEI Pharma paves the way for a new era for altcoins in corporate finance. But Litecoin does not stop there. It now aims for ETFs, as demonstrated by the recent postponement of the SEC's ruling on Litecoin and Solana ETFs. While bitcoin establishes itself among tech giants, LTC explores new markets. Step by step, the gray crypto moves toward the light.